阿奇霉素联合头孢噻肟钠对慢性阻塞性肺疾病患者肺功能的影响

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Azithromycin combined with Cefotaxime Sodium on pulmonary function in patients with chronic obstructive pulmonary disease.Methods One hundred patients with chronic obstructive pulmonary disease admitted to Shekou People′s Hospital from April 2017 to April 2018 were selected as the subjects of this study,and were divided into the control group(n=50)and the study group(n=50)by random lottery.The control group was treated with conventional basic treatment,while the study group was treated with Azithromycin combined with Cefotaxime Sodium.The lung function indexes before and after treatment,the clinical symptom scores before and after treatment,and the clinical treatment effect were compared between the two groups.Results Before treatment,there were no significant differences in the forced vital capacity(FVC),maximum ventilator volume(MVV),and forced expiratory volume in 1 second(FEV1)between the two groups(P＞0.05).After treatment,the FVC of patients of the study group was(2.40±0.45)L,the MVV was(88.95±2.65)L/min,and the FEV1 was(1.88±0.13)L,which were higher than those in the control group([2.15±0.20]L,[80.10±1.15]L/min,[1.40±0.35]L),the differences were statistically significant(P＜0.05).Before treatment,there were no statistically significant differences in the scores of chronic cough and expectoration,shortness of breath,wheezing chest tightness,and fatigue and weight loss between the two groups(P＞0.05).The score of chronic cough and expectoration after treatment was(1.18±0.07)points,the score of shortness of breath after treatment was(1.05±0.01)points,the score of wheezing chest tightness after treatment was(1.18±0.06)points,and the score of fatigue and weight loss after treatmentwas(1.38±0.04)points in the study group,all lower than those in the control group([1.85±0.05],[2.21±0.05],[2.03±0.07],[1.96±0.07]points),the differences were statistically significant(P＜0.05).The total effective rate was 96.00%in the study group,which was higher than that in the control group accounting for 76.00%(P＜0.05).Conclusion The treatment of Azithromycin combined with Cefotaxime Sodium in patients with chronic obstructive pulmonary disease ismore effective,can effectively improve the lung function index and symptom index,and has important clinical application value.

Key words： Azithromycin Cefotaxime Sodium Chronic obstructive pulmonary disease Effect Lung function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIANG Wei
	HUANG Jian-ling

Cite this article:

LIANG Wei,HUANG Jian-ling. Effect of Azithrom ycin combined with Cefotaxime Sodium on pulmonary function in patients with chronic obstructive pulmonary disease[J]. 中国当代医药, 2020, 27(9): 53-56.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I9/53

[1]	袁尚红，熊云峰，任雅芳，等.阿奇霉素配合头孢噻肟钠治疗慢阻肺患者的疗效及安全性评价[J].当代医学，2017，23（36）：108-109.
[2]	赵钰玲，董娅，范亚莉，等.阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压临床疗效的Meta分析[J].实用心脑肺血管病杂志，2018，26（3）：1-5.
[3]	张业金.热毒宁注射液联合头孢噻肟钠治疗慢性阻塞性肺疾病合并肺部感染的疗效观察[J].齐齐哈尔医学院学报，2018，39（24）：2899-2901.
[4]	李允，李硕，罗裕文，等.N-乙酰半胱氨酸联合阿奇霉素对慢性阻塞性肺疾病模型大鼠氧化应激的影响[J].中国病理生理杂志，2016，32（5）：798-803.
[5]	洪路贤，王秋婷.阿奇霉素片联合阿托伐他汀钙片治疗慢性阻塞性肺疾病合并肺动脉高压的临床研究[J].中国临床药理学杂志，2018，34（18）：2134-2136，2174.
[6]	张媚霞，孙志芬，曲桂红，等.小剂量阿奇霉素联合噻托溴铵治疗老年慢性阻塞性肺疾病的临床疗效观察[J].实用心脑肺血管病杂志，2016，24（7）：111-114.
[7]	韩利，张筠，张铁栓，等.长期小剂量阿奇霉素联合布地奈德/福莫特罗治疗Ⅲ、Ⅳ级COPD稳定期患者的疗效[J].实用医学杂志，2016，32（17）：2918-2920.
[8]	佘亚南.慢性阻塞性肺疾病合并慢性肺心病的治疗分析[J].系统医学，2017，2（15）：42-43，46
[9]	姜晓亮，刘雪，刘云鹏，等.Sestrin2在吸烟诱导的肺泡Ⅱ型上皮细胞损伤中的作用机制[J].中国比较医学杂志，2018，28（5）：46-52.
[10]	刘旭东，吴俊丽，刘云，等.辛伐他汀联合阿奇霉素治疗老年慢性阻塞性肺疾病合并肺动脉高压患者的疗效[J].实用医学杂志，2016，32（7）：1199-1200.
[11]	王炳炽.阿奇霉素联合N-乙酰半胱氨酸治疗稳定期COPD疗效[J].临床肺科杂志，2018，23（11）：2102-2104，2107.
[12]	李敏，兰风金，张金焕，等.整体护理辅助阿奇霉素对慢性阻塞性肺疾病的临床效果观察[J].国际护理学杂志，2016，35（24）：3449-3451.
[13]	李涛，刘向群，刘景双，等.小剂量阿奇霉素对稳定期老年慢性阻塞性肺疾病患者外周血内TNF-α、IL-8、CRP水平及肺功能的影响[J].中国药物警戒，2016，13（8）：460-463.
[14]	郭彩霞.阿奇霉素经TLR-4/NF-κB信号通路干预COPD大鼠炎症的机制研究[J].重庆医学，2016，45（12）：1612-1615.
[15]	蒋亚林，荣令，唐超，等.比较阿奇霉素与罗红霉素在预防慢性阻塞性肺疾病急性加重中的作用及不良反应[J].国际呼吸杂志，2018，38（16）：1220-1224.
[16]	郑岩，罗琳琳，李秋根，等.阿法骨化醇联合阿奇霉素治疗慢性阻塞性肺疾病急性加重期的疗效[J].南昌大学学报（医学版），2017，57（4）：21-23，46.
[17]	赵建.阿奇霉素联合孟鲁司特钠治疗老年支原体肺炎的临床疗效观察[J].中国医药科学，2019，9（4）：28-30，122.
[18]	王刚.炎琥宁辅助治疗小儿支原体肺炎的效果及其对免疫功能的影响[J].中国当代医药，2018，25（1）：101-103.